{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:52:09Z","timestamp":1771620729061,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to explore novel microRNAs in plasma for predicting chemoresistance in adjuvant chemotherapy for patients with gastric cancer (GC). We used the Toray 3D-Gene microRNA array-based approach to compare preoperative plasma microRNA levels between GC patients with and without recurrences after curative gastrectomy. All patients underwent adjuvant chemotherapy with S-1, an oral fluoropyrimidine. Of 2566 candidates, six candidate microRNAs (miR-1229-3p, 1249-5p, 762, 711, 1268a and 1260b), which were highly expressed in the preoperative plasma of patients with subsequent recurrences, were selected. In a large-scale validation analysis by quantitative RT-PCR, we focused on high plasma levels of miR-1229-3p, which was an independent poor prognostic factor for recurrence free survival (<jats:italic>P<\/jats:italic>\u2009=\u20090.009, HR\u2009=\u20093.71). Overexpression of miR-1229-3p in GC cells induced significant chemoresistance to 5-fluorouracil (5-FU), up-regulation of thymidylate synthase (TS) and dihydroprimidine dehydrogenase (DPD) and down-regulation of SLC22A7 both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. Intraperitoneal injection of miR-1229-3p in mice induced significant chemoresistance to 5-FU, accompanied by high levels of miR-1229-3p in plasma and tumor tissue. These findings suggest that plasma miR-1229-3p might be a clinically useful biomarker for predicting chemoresistance to S-1 and selecting other or combined intensive chemotherapy regimens in GC patients.<\/jats:p>","DOI":"10.1038\/s41598-020-59939-8","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T11:03:29Z","timestamp":1582283009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Keiji","family":"Nishibeppu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-6550","authenticated-orcid":false,"given":"Taisuke","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Arita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-7272","authenticated-orcid":false,"given":"Toshiyuki","family":"Kosuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigo","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"59939_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87\u2013108 (2015).","journal-title":"CA: a cancer journal for clinicians"},{"key":"59939_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ags3.12284","volume":"3","author":"S Komatsu","year":"2019","unstructured":"Komatsu, S. & Otsuji, E. Essential updates 2017\/2018: Recent topics in the treatment and research of gastric cancer in Japan. Annals of gastroenterological surgery 3, 581\u2013591 (2019).","journal-title":"Annals of gastroenterological surgery"},{"key":"59939_CR3","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.3748\/wjg.v12.i20.3237","volume":"12","author":"A Gallo","year":"2006","unstructured":"Gallo, A. & Cha, C. Updates on esophageal and gastric cancers. World journal of gastroenterology 12, 3237\u20133242 (2006).","journal-title":"World journal of gastroenterology"},{"key":"59939_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1053\/srao.2002.30817","volume":"12","author":"LL Gunderson","year":"2002","unstructured":"Gunderson, L. L. Gastric cancer\u2013patterns of relapse after surgical resection. Seminars in radiation oncology 12, 150\u2013161 (2002).","journal-title":"Seminars in radiation oncology"},{"key":"59939_CR5","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako, M. et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 29, 4387\u20134393 (2011).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"59939_CR6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto, S. et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. The New England journal of medicine 357, 1810\u20131820 (2007).","journal-title":"The New England journal of medicine"},{"key":"59939_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4052-z","volume":"18","author":"K Nishibeppu","year":"2018","unstructured":"Nishibeppu, K. et al. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer. BMC cancer 18, 108 (2018).","journal-title":"BMC cancer"},{"key":"59939_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research 18, 997\u20131006 (2008).","journal-title":"Cell research"},{"key":"59939_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature reviews. Genetics 9, 102\u2013114 (2008).","journal-title":"Nature reviews. Genetics"},{"key":"59939_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838 (2005).","journal-title":"Nature"},{"key":"59939_CR11","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105, 10513\u201310518 (2008).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"59939_CR12","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America 108, 5003\u20135008 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"59939_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature cell biology 13, 423\u2013433 (2011).","journal-title":"Nature cell biology"},{"key":"59939_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3892\/mmr.2016.5413","volume":"14","author":"M Zhu","year":"2016","unstructured":"Zhu, M. et al. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. Molecular medicine reports 14, 1742\u20131750 (2016).","journal-title":"Molecular medicine reports"},{"key":"59939_CR15","doi-asserted-by":"publisher","first-page":"e12007","DOI":"10.1097\/MD.0000000000012007","volume":"97","author":"B Fan","year":"2018","unstructured":"Fan, B. et al. miR-17-92 cluster is connected with disease progression and oxaliplatin\/capecitabine chemotherapy efficacy in advanced gastric cancer patients: A preliminary study. Medicine 97, e12007 (2018).","journal-title":"Medicine"},{"key":"59939_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3233\/CBM-161732","volume":"18","author":"M Qi","year":"2017","unstructured":"Qi, M., Liu, D. & Zhang, S. MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer. Cancer biomarkers: section A of Disease markers 18, 451\u2013458 (2017).","journal-title":"Cancer biomarkers: section A of Disease markers"},{"key":"59939_CR17","doi-asserted-by":"crossref","first-page":"51190","DOI":"10.18632\/oncotarget.17087","volume":"8","author":"M Li","year":"2017","unstructured":"Li, M., Gu, K., Liu, W., Xie, X. & Huang, X. MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer. Oncotarget 8, 51190\u201351199 (2017).","journal-title":"Oncotarget"},{"key":"59939_CR18","doi-asserted-by":"publisher","first-page":"11347","DOI":"10.3748\/wjg.v20.i32.11347","volume":"20","author":"XL Zhang","year":"2014","unstructured":"Zhang, X. L. et al. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World journal of gastroenterology 20, 11347\u201311355 (2014).","journal-title":"World journal of gastroenterology"},{"key":"59939_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","volume":"5","author":"CC Pritchard","year":"2012","unstructured":"Pritchard, C. C. et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer prevention research (Philadelphia, Pa.) 5, 492\u2013497 (2012).","journal-title":"Cancer prevention research (Philadelphia, Pa.)"},{"key":"59939_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng, A. K. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta paediatrica (Oslo, Norway: 1992) 96, 644\u2013647 (2007).","journal-title":"Acta paediatrica (Oslo, Norway: 1992)"},{"key":"59939_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1211\/0022357055966","volume":"57","author":"Y Kobayashi","year":"2005","unstructured":"Kobayashi, Y. et al. Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). The Journal of pharmacy and pharmacology 57, 573\u2013578 (2005).","journal-title":"The Journal of pharmacy and pharmacology"},{"key":"59939_CR22","first-page":"2203","volume":"47","author":"GD Heggie","year":"1987","unstructured":"Heggie, G. D., Sommadossi, J. P., Cross, D. S., Huster, W. J. & Diasio, R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer research 47, 2203\u20132206 (1987).","journal-title":"Cancer research"},{"key":"59939_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1349-7006.2000.tb00866.x","volume":"91","author":"Y Ishikawa","year":"2000","unstructured":"Ishikawa, Y. et al. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil. Japanese journal of cancer research: Gann 91, 105\u2013112 (2000).","journal-title":"Japanese journal of cancer research: Gann"},{"key":"59939_CR24","first-page":"889","volume":"17","author":"A Takabayashi","year":"2000","unstructured":"Takabayashi, A. et al. Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy. International journal of oncology 17, 889\u2013895 (2000).","journal-title":"International journal of oncology"},{"key":"59939_CR25","first-page":"341","volume":"19","author":"K Uchida","year":"2001","unstructured":"Uchida, K., Hayashi, K., Kuramochi, H. & Takasaki, K. Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion. International journal of oncology 19, 341\u2013346 (2001).","journal-title":"International journal of oncology"},{"key":"59939_CR26","doi-asserted-by":"crossref","first-page":"24076","DOI":"10.18632\/oncotarget.8119","volume":"7","author":"Z Tan","year":"2016","unstructured":"Tan, Z. et al. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt\/beta-catenin signaling in breast cancer. Oncotarget 7, 24076\u201324087 (2016).","journal-title":"Oncotarget"},{"key":"59939_CR27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/0959-8049(94)00216-R","volume":"30a","author":"A Beck","year":"1994","unstructured":"Beck, A. et al. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. European journal of cancer (Oxford, England: 1990) 30a, 1517\u20131522 (1994).","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"59939_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/bi00700a012","volume":"13","author":"DV Santi","year":"1974","unstructured":"Santi, D. V., McHenry, C. S. & Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 13, 471\u2013481 (1974).","journal-title":"Biochemistry"},{"key":"59939_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1021\/bi00702a016","volume":"13","author":"PV Danenberg","year":"1974","unstructured":"Danenberg, P. V., Langenbach, R. J. & Heidelberger, C. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry 13, 926\u2013933 (1974).","journal-title":"Biochemistry"},{"key":"59939_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10120-013-0249-7","volume":"17","author":"A Nakamura","year":"2014","unstructured":"Nakamura, A. et al. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 17, 188\u2013195 (2014).","journal-title":"Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association"},{"key":"59939_CR31","first-page":"528","volume":"4","author":"A Tashiro","year":"2014","unstructured":"Tashiro, A. et al. High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy. American journal of cancer research 4, 528\u2013536 (2014).","journal-title":"American journal of cancer research"},{"key":"59939_CR32","first-page":"661","volume":"1","author":"S Nishino","year":"2013","unstructured":"Nishino, S., Itoh, A., Matsuoka, H., Maeda, K. & Kamoshida, S. Immunohistochemical analysis of organic anion transporter 2 and reduced folate carrier 1 in colorectal cancer: Significance as a predictor of response to oral uracil\/ftorafur plus leucovorin chemotherapy. Molecular and clinical oncology 1, 661\u2013667 (2013).","journal-title":"Molecular and clinical oncology"},{"key":"59939_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science (New York, N.Y.) 327, 198\u2013201 (2010).","journal-title":"Science (New York, N.Y.)"},{"key":"59939_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/nar\/gkt852","volume":"42","author":"LF Gebert","year":"2014","unstructured":"Gebert, L. F. et al. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic acids research 42, 609\u2013621 (2014).","journal-title":"Nucleic acids research"},{"key":"59939_CR35","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1245\/s10434-017-6078-x","volume":"24","author":"H In","year":"2017","unstructured":"In, H. et al. Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database. Annals of surgical oncology 24, 3683\u20133691 (2017).","journal-title":"Annals of surgical oncology"},{"key":"59939_CR36","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/sj.bjc.6605608","volume":"102","author":"M Tsujiura","year":"2010","unstructured":"Tsujiura, M. et al. Circulating microRNAs in plasma of patients with gastric cancers. British journal of cancer 102, 1174\u20131179 (2010).","journal-title":"British journal of cancer"},{"key":"59939_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/bjc.2011.198","volume":"105","author":"S Komatsu","year":"2011","unstructured":"Komatsu, S. et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. British journal of cancer 105, 104\u2013111 (2011).","journal-title":"British journal of cancer"},{"key":"59939_CR38","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/bjc.2011.453","volume":"105","author":"R Morimura","year":"2011","unstructured":"Morimura, R. et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. British journal of cancer 105, 1733\u20131740 (2011).","journal-title":"British journal of cancer"},{"key":"59939_CR39","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/bjc.2011.588","volume":"106","author":"H Konishi","year":"2012","unstructured":"Konishi, H. et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. British journal of cancer 106, 740\u2013747 (2012).","journal-title":"British journal of cancer"},{"key":"59939_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bjc.2012.546","volume":"108","author":"T Kawaguchi","year":"2013","unstructured":"Kawaguchi, T. et al. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. British journal of cancer 108, 361\u2013369 (2013).","journal-title":"British journal of cancer"},{"key":"59939_CR41","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/bjc.2014.451","volume":"111","author":"S Komatsu","year":"2014","unstructured":"Komatsu, S. et al. Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. British journal of cancer 111, 1614\u20131624 (2014).","journal-title":"British journal of cancer"},{"issue":"Suppl 1","key":"59939_CR42","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1517\/14712598.2012.681373","volume":"12","author":"S Komatsu","year":"2012","unstructured":"Komatsu, S. et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert opinion on biological therapy 12(Suppl 1), S53\u201359 (2012).","journal-title":"Expert opinion on biological therapy"},{"key":"59939_CR43","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/bjc.2013.148","volume":"108","author":"S Hirajima","year":"2013","unstructured":"Hirajima, S. et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. British journal of cancer 108, 1822\u20131829 (2013).","journal-title":"British journal of cancer"},{"key":"59939_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06137-8","volume":"7","author":"T Imamura","year":"2017","unstructured":"Imamura, T. et al. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer. Scientific reports 7, 5708 (2017).","journal-title":"Scientific reports"},{"key":"59939_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/jb\/mvj086","volume":"139","author":"K Nagino","year":"2006","unstructured":"Nagino, K. et al. Ultrasensitive DNA chip: gene expression profile analysis without RNA amplification. Journal of biochemistry 139, 697\u2013703 (2006).","journal-title":"Journal of biochemistry"},{"key":"59939_CR46","doi-asserted-by":"publisher","first-page":"e49145","DOI":"10.1371\/journal.pone.0049145","volume":"7","author":"E Giovannetti","year":"2012","unstructured":"Giovannetti, E. et al. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer. PloS one 7, e49145 (2012).","journal-title":"PloS one"},{"key":"59939_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25, 402\u2013408 (2001).","journal-title":"Methods (San Diego, Calif.)"},{"key":"59939_CR48","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research 29, e45 (2001).","journal-title":"Nucleic acids research"},{"key":"59939_CR49","doi-asserted-by":"publisher","first-page":"106538","DOI":"10.18632\/oncotarget.20860","volume":"8","author":"T Imamura","year":"2017","unstructured":"Imamura, T. et al. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer. Oncotarget 8, 106538\u2013106550 (2017).","journal-title":"Oncotarget"},{"key":"59939_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0929-3","volume":"18","author":"J Kiuchi","year":"2019","unstructured":"Kiuchi, J. et al. Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma. Molecular cancer 18, 2 (2019).","journal-title":"Molecular cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59939-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:22:15Z","timestamp":1670311335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59939-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59939-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3161"}}